Soleno Therapeutics (NASDAQ:SLNO) Stock Price Expected to Rise, Cantor Fitzgerald Analyst Says
Soleno Therapeutics (NASDAQ:SLNO – Get Free Report) had its price target increased by analysts at Cantor Fitzgerald from $67.00 to $123.00 in a report issued on Thursday,Benzinga reports. The firm presently has an “overweight” rating on the stock. Cantor Fitzgerald’s price objective would suggest a potential upside of 70.86% from the stock’s previous close. A […]
More Stories
Phillips Financial Management LLC Has $2.28 Million Stock Holdings in NVIDIA Co. (NASDAQ:NVDA)
Phillips Financial Management LLC increased its position in shares of NVIDIA Co. (NASDAQ:NVDA – Free Report) by 14.6% during the...
Impact Capital Partners LLC Takes $9.96 Million Position in NVIDIA Co. (NASDAQ:NVDA)
Impact Capital Partners LLC purchased a new position in shares of NVIDIA Co. (NASDAQ:NVDA – Free Report) during the 4th...
Lazard Freres Gestion S.A.S. Sells 211,408 Shares of NVIDIA Co. (NASDAQ:NVDA)
Lazard Freres Gestion S.A.S. decreased its position in shares of NVIDIA Co. (NASDAQ:NVDA – Free Report) by 15.2% in the...
CFO4Life Group LLC Has $4.76 Million Position in NVIDIA Co. (NASDAQ:NVDA)
CFO4Life Group LLC lifted its holdings in shares of NVIDIA Co. (NASDAQ:NVDA – Free Report) by 3.9% in the fourth...
NVIDIA Co. (NASDAQ:NVDA) is 1776 Wealth LLC’s 8th Largest Position
1776 Wealth LLC raised its position in NVIDIA Co. (NASDAQ:NVDA – Free Report) by 1.1% in the 4th quarter, HoldingsChannel.com...
NVIDIA Co. (NASDAQ:NVDA) Shares Acquired by Madison Wealth Partners Inc
Madison Wealth Partners Inc boosted its position in shares of NVIDIA Co. (NASDAQ:NVDA – Free Report) by 1.8% in the...